GlassScriptPhysician profile
Mark A Thiele
NPI 1992708523
$4,823.19
in general payments reported to CMS, 2019-2025
12 companies · $1,857 in 2025
The $1,857 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $1,721 · 2023: $339 · 2024: $798 · 2025: $1,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,509 · Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,508.98 |
| Food and Beverage | $1,485.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,804.80 | 2021-2024 | Inhance, Na |
| Stryker Corporation | $1,327.34 | 2024-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Tornier Perform Reversed Augmented Glenoid |
| Moximed, INC | $785.57 | 2025 | Misha Knee System, Small, Left |
| Depuy Synthes Sales INC. | $536.22 | 2021-2025 | Attune |
| Abbott Laboratories | $122.40 | 2023 | Octrode |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $45.29 | 2025 | Exparel, Iovera |
| Nalu Medical, INC. | $38.48 | 2025 | Nalu Neurostimulation System |
| Ethicon US, LLC | $28.24 | 2025 | Surgiflo Hemostatic Matrix |
| Vertex Pharmaceuticals Incorporated | $21.99 | 2025 | |
| Davol INC. | $17.00 | 2025 | Arista |
| Bioventus LLC | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Thiele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.